trial · primary record
Nivolumab
Hepatocellular Carcinoma
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 31 |
| Primary completion | 2030-06-01 |
| Primary endpoint | Number of Patients Precluded From Surgery |
| Registry ID | NCT04658147 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:03.590Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04658147
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.